Transcripts For KCSM Taiwan Outlook 20140112 : vimarsana.com

KCSM Taiwan Outlook January 12, 2014

The season kyle won since two thousand and eight. And what is taiwans niche in biotechnology. To learn more watch ill call them today because we are delighted to have talked to john c lee whos the chairman of the Development Center for biotechnology that i want to share with this the state of Biotechnology Development here on the island. Whoa come to cool then cut the lead thank you for inviting me to reprint it. It was common to have the pm programme. I guess said you know i mean over the last few years steel Bar Technology has been on the government. The Team Priorities in terms of development and promotion its a its been a worldwide trend this wallet is allowed inches for example on the Financial Sector interests of investment into the fall taking history. What is the state of the you know ill take the fall of the income one today come here with since many other countries. There also was so focused on the beach. Isaiah taiwans bioTechnology Industry is still in the early stage but is about ready to take off all in good time. Always speaking i think biotechnology started in about nineteen seven the great many seventies early eighties and now. Sorry its been thirty forty years nah but no one has been working on this subject as a government priority for more than twenty years so its finally up the tent on the assessor and we said that i love fall the foundations and family in the last full five years. The indices started to up. Mix very good and lots of capital has been invested into the of the Biotechnology Pharmaceuticals sector soon and though was this you are ill angle on the wood tile one is leaving for example compete with other countries you know what were the areas with sample with the talk about. No curing illness like you know if he swapped answers to things and the the other things you know if this were the sky one really cool technique. But it bears several different in that state you can talk about the nature of the stress of it on. Generally speaking i think ireland has a very Strong Innovation based in biotechnology and Life Sciences. This has been needed for four last twenty years of government strong support. We have invested huge amount of our findings to support academia of the Polar Research institute and their flaws of rizzo we have accumulated many discoveries in interactive allman and on genomics. And so so we have a strong our innovation bays and also out of the mosque. Ten fifteen years. We also spend a lot of effort and resources to build the infrastructure fall at the biotechnology and pharmaceutical industry for example goes on. When you just do the research in the academe and that is very different from carrying it all the way to cover some admission that she had to fight on any moment you have to do the pre clinical before you can try on humans so and then you the Clinical Trial wh the regulatory issues. And so on so so theyre a lot of info section need to be built and we had a reasonable Good Development in the section right now and most importantly i think god. We have access to Greater China market thats thats very important. You can so that anna on how well it is built upon a bower of pseudo market min and then not been the abundant Capital Market is another important factor so those of the dd i think going good for the enron imploded rawlinson in terms of attracting Biotechnology Development in taiwan. But in terms of technology or intents of the column. Up in the future of put a show this they also carry us we do we think a wee wee. I think i went to play the role of fall ish and prevent diseases they have many diseases this is it the titans series has an ear infection. Its only her up in kansas. Typical mum been there many other up a sian popular in asian diseases those are some of them really have no marketing the other part of the war. So i think we have done a lot of phone will work in this area for example not all the new mod rock to bowman in its non Small Cell Lung Cancer lung cancer is is a very popular here and this is has to do with economics of the fifteen of our population in asia and this is the at will with developing a very unique rock that is very different from those useful caucasians. And that new truck a balm for lung cancer would be a day of a potential all this and also bottles taking history is something of course is a lot and shes only in taiwan the war why but it is something for exampleeopl oulday is top heavy because had the beginning stages. You need to do on an investment not just in terms of capital folsom tears of Human Resources led the nba you dont know whether to go r and d is actually on the fly. This has to be successful commercial. So of what this then you know it the attraction. To all these many other investors who are r and d personnel to continue to heal people to come and spend your time and effort into the development of how egal files. I thinkio akenrom us a cause man people in our gden. It takes a long time to delve in uganda when he says it has to go through the Clinical Phase two on phase two or three and so on so it typically would take more than ten years and iestmt also reacheda huge the soul of who i always describe of biotechnology pharmaceutical a diploma as every day. Really a full marathon and if full one to run amok so thats pretty diffilt but if you do it by relay them to use the money is not about the cia. So we each play at bedtime and in the relay and so thats how would you need to to what extent its the right one and theyre full of many investment as you said is is top heavy. And when the investing that. Its kind of flower each to get to there is also know that freud developed a special of flavorful kept the market and that many investment in venice on those company that doesnt have written you keep it doesnt thats still not making money but it already have. What i can pipeline and they are indeed have eyed peas did it happens and eyed peas and also maybe some top approval in certain states if involvement that translate into a future that is ok and got to the eu or the chairman of the two film incentive of technology in taiwan. Tell its a little bit about his head. What the center was set out in nineteen eighty four which is pretty learning about nine years says about the same time as the bioTechnology Industry of taking office in United States is of those community by ktv name of pakistanis out that this is the future industry but saw and now we have about four hundred people in the center of the center is pretty commission to accelerate the growth of our bioTechnology Industry in taiwan but at the kennedy we play arrow of reaching the Academic Research and commercialization. So this center is the so called Development Center is now the Research Team of basic research but we do. Trying to translate. Many of basic research into Clinical Trial and then into commercialization so thats thats what the sentence thats most of time and we do he to complent of resrch d involvement in house also have a compound of commercial development t help the industry investmen and licensing incorporation and since they are many other things that you said your Research Centers round the island also will involve corker you knon d all take a look of old college in the u s attorney in the office. Note that the bill was sent to pope of technology tried to integrate and courtney. The efforts of the different universities for Research Centers to run the eye. Its that song that says always said a difficulty to task and allison the question but i think taiwan as that of the nation we do have a National Research program and in biotechnology and bio pharmaceutical so its true love is National Development program did according nation in terms of Technology Research and. But in terms of coming to lead a nation and Industry Development which the ecb is our center to play a more important role. There are we to say about that and that many different functions of inches the ages of not just technology. Of course busiest of all the licensing incubation in stock so we do have a regional phase which is sell it to serve at the Team Villages all reach to all the academic and basic research. So we we go and take a look of what would they have been doing and how we can link them to get this over and tried to. Sometimes license from basic breezes are all from the International Community did the thirty seats of discovery. Then we carry out some good moments and maybe if on god or some may be carried out by industry and then we also have the office of that said the licensing office. And Incubation Office in and of that. That has about twenty some companies that any time so in cuba a Small Company we helped that Large Companies rios help International Community to college and high winds or to call their breweries taiwans biotechnology is that you all Biotechnology Company. So thats how we we played the role of breaching the base and the sister come into the ocean and weeds International Community but that is a surly very deplorable interests of the aisle the aggregate resources but also developing platforms for exchanges and cooperation which is something i think both acknowledged the spirit. We need to take the first break of the program will be back in just a few minutes. I know i do. Sells. Says the sea welcome back to the second part of the world mt on the cob while the army hopes to reap will will will continue our conversation with dr jones the leak was determined enough that the film incentive of technology in taiwan. Luckily what is the market capitalization full of tech in taiwan is it is something thats growing its numbers increasing. Please calling and a fairfax. In that in two thousand and nine which is about five years ago for four and half years ago here on the monkey kept the dish and was among the cat was only about three billion us dollar but today is eighteen billion years only six times over six times over yet. Its been five years here so thats it baby. This astonishing on a Mountain Road from the parties do today an increasing number of top Company Listed company. Ok have partly due to the increase in value and expansion in their business and revenue. But this is some this is the that they kept a market thats why i did a good beginning idea mentioned above the oblong been kept open. In taiwan is a very very important factor for bioTechnology Industry and by now the fact that on the market is very active and he did so also because i p os and then was supported by investors in detail and thats a has has attracted many Top Biotech Companies to come to taiwan even from other countries. Of course but the light if you look at status of taiwan while taking this to the revenue is about eight to nineteen ninety he is jealous of my weekend is of course but individual company was the monaco is a very good is usually made of thirty times so far. Learning to share. So it isnt a e l o u them all but dead. I think that is very attractive. Its now off and then in taiwan over was speaking about taking the city is divided into three sectors of the most of the colors of it. Many could devise new section in the other very important part of it and has a caveat on the phone strands from the islands ict disadvantages to the extent of the surprise that the Research Based Biotechnology Company has about one thirty show. And by the revenue laws in these derives from the pharmaceutical and medical technology sector. So did research raised about Technology Companies they are typically as though also eyed peas owns the love of thought intangible values it but the revenue. It was coming off hours. Being in czech Capital Market. Can. So pull those of Research Based Biotech Company does something very special indeed to know and that is is very important part of the taiwan said development. So of we have always known. For the last two three years internationally. Everybody that if this kept the market rees was a lot of suspicion but i think full full five years it has been quite stable and the reason is its been that i think we have sung the foundations for the attack. And though this taco bit above the Heart Research foundation. Though will be staggered years. You know that your national r and d research and Development Program for biotechnology and pharmaceuticals one to six significance of such a national strategy. In this emerging industry. Well i a i think. At that point in our area and that the initial program would help to integrate different part of research and then into focus and so thats system. No its that important purpose the insect me that that ed small findings that small resources. When they showed program this season the funds on average not very precisely but roughly about a hundred million us dollars per year and it has been katie on for more than. Colins of years so i had set up in it to moab for him throughout different of them in different stages and everyone supported in the city but it has ended her falling the fall but only under the is beyond me. I think we get to stay stuck out as i said its ready to take up and pay and those given the fact that the you know we have such a growing industry and theres a lot of you know inches on the capital. Keep coming the billet the sector also serve as a note to break going direct indicated that i want in terms of the hill having it mitch is really you know showing strength in the action. Villa to become one of the leaders. Being the politicking. Well i think we are still lot compared to the european or United States was still behind on a bead of the seventies is a small niche to industry as the eyes of the paul willis the foundation because it but i think we should play a leadership row in indonesia where else can wait the decency image thats right this is the end and i think we do have a good role to play and it tends to be one of the leaders and our home. And in Capital Markets a poll shows that up primarily this support innovation news and lets go back to us to be to your analogy of running the relay they will just add that you know fall technologies a long process. It could easily take over ten years before anything gets taken from the lavatory into commercialization. But given the fact that you know its such a long process is a lot of the basement. No capital ill scoop Human Resources and a new use the analogy of running but you know marathon in the running of the day can you give those who want t tell about how you making that comparison. Cellphone run the relay to the neo two column in the politicking. Oh well. I think this related facility a few characteristics. Ok this all of this relay and has to be international. Its not just when we think i want the whole case is that taiwan has sentenced a this is the innovation and discovery maybe theyve all been especially open Pit Development costs. Typical uses a high noon in the mall of this country exists but we have good Innovation Base could get it all in the palm of the structure of the station the train station known far and then. Maybe be the other but time to go to International Company of the International Market because the pharmaceutical law in this product is different from the electronics. You can sell electronic proud that all was in any country in quite easily without much radiate regulations and about biotechnology and pharmaceutical product is unregulated and see if you dont get licensed and if you dont do Clinical Trial in particular country for example United States and if you dont get fda approval this you will be able to sell anything in United States is now so we have to and also selling the pharmaceutical part that requires a lot of resources that experience and also channels and soul. Um we have to call the great deliberation international use. Radio one very important effect and thats part of everyday folk. So thats the first characteristic secondly the biotechnology and pharmaceutical to baldwin involve many different disciplines at different stages and only or maybe chemistry. Amy biology. Then later maybe be any more tests maybe the cell biology maybe the transformational power Party Express that the dark to that as human. And then made a pot involved in human Clinical Trial. That the gross medical docto

© 2025 Vimarsana